These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 1916614)

  • 1. Effects of administration route on valproate pharmacokinetics in the rabbit.
    Bourin M; Guenzet J; Thomare P; Kergueris MF; Ortega A; Larousse C
    Fundam Clin Pharmacol; 1991; 5(4):331-9. PubMed ID: 1916614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of administration route on pharmacokinetics of viloxazine in the rabbit.
    Thomare P; Bourin M; Kergueris MF; Ortega A; Larousse C
    Methods Find Exp Clin Pharmacol; 1992 Mar; 14(2):125-9. PubMed ID: 1598024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioavailability of valproate after gastric and direct intestinal administration in rats.
    Yeomans ND; Vajda FJ; Baldas J
    Clin Exp Pharmacol Physiol; 1982; 9(2):173-7. PubMed ID: 6813007
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetics of valproate after multiple-dose oral and intravenous infusion administration: gastrointestinal-related diurnal variation.
    Hussein Z; Mukherjee D; Lamm J; Cavanaugh JH; Granneman GR
    J Clin Pharmacol; 1994 Jul; 34(7):754-9. PubMed ID: 7929870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between valproic acid and acyclovir after intravenous and oral administration in a rabbit model.
    van Jaarsveld MF; Walubo A; du Plessis JB
    Basic Clin Pharmacol Toxicol; 2007 Dec; 101(6):434-40. PubMed ID: 18028106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics and muscle histopathology of intramuscular valproate.
    Gallo BV; Slater JD; Toledo C; DeToledo J; Ramsay RE
    Epilepsy Res; 1997 Jul; 28(1):11-5. PubMed ID: 9255595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A pharmacokinetic model for percutaneous absorption of valproic acid and prediction of drug disposition.
    Ogiso T; Ito Y; Iwaki M; Atago H; Yamamoto Y
    J Pharmacobiodyn; 1988 Jun; 11(6):444-52. PubMed ID: 3139859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Absorption of 1-deamino-8-D-arginine vasopressin from different regions of the gastrointestinal tract in rabbits.
    Lundin S; Vilhardt H
    Acta Endocrinol (Copenh); 1986 Jul; 112(3):457-60. PubMed ID: 3751460
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of administration route on pharmacokinetics of aspirin in the rabbit.
    Kergueris MF; Bourin M; Larousse C; Lasserre MP; Ortega A
    Methods Find Exp Clin Pharmacol; 1988 Mar; 10(3):171-5. PubMed ID: 3386327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Buffering the stomach content enhances the absorption of diflunisal in man.
    Nuernberg B; Brune K
    Biopharm Drug Dispos; 1989; 10(4):377-87. PubMed ID: 2547464
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Biopharmaceutical studies on indomethacin. I. Analysis of concentration time course in rabbit plasma after intravenous administration and relationship between dosage form and absorption after intraduodenal administration].
    Moriyama M; Saito M; Awazu S; Hanano M; Nogami H
    Yakugaku Zasshi; 1971 Nov; 91(11):1217-22. PubMed ID: 5169129
    [No Abstract]   [Full Text] [Related]  

  • 12. Pharmacokinetics of DA-7867, a new oxazolidinone, after intravenous or oral administration to rats: intestinal first-pass effect.
    Bae SK; Chung WS; Kim EJ; Rhee JK; Kwon JW; Kim WB; Lee MG
    Antimicrob Agents Chemother; 2004 Feb; 48(2):659-62. PubMed ID: 14742232
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Theophylline absorption and disposition in rabbits: oral, intravenous, and concentration-dependent kinetic studies.
    El-Yazigi A; Sawchuk RJ
    J Pharm Sci; 1981 Apr; 70(4):452-6. PubMed ID: 7229966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absorption of valproic acid suppositories in human volunteers.
    Holmes GB; Rosenfeld WE; Graves NM; Remmel RP; Carlson GH; Kriel RD
    Arch Neurol; 1989 Aug; 46(8):906-9. PubMed ID: 2502974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of valproic acid in guinea-pigs with biliary abnormality.
    Yu HY; Shen YZ
    J Pharm Pharmacol; 1991 Jul; 43(7):470-4. PubMed ID: 1682459
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug interaction. Effects of salicylate on pharmacokinetics of valproic acid in rats.
    Yu HY; Shen YZ; Sugiyama Y; Hanano M
    Drug Metab Dispos; 1990; 18(1):121-6. PubMed ID: 1970771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single dose and steady state pharmacokinetics of valproic acid in adult epileptic patients.
    Miljković B; Pokrajac M; Varagić V; Lević Z
    Int J Clin Pharmacol Res; 1991; 11(3):137-41. PubMed ID: 1809700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relative bioavailability of different valproic acid formulations.
    Franke G; Diletti E; Hoffmann C; Zschiesche M; Scheuch E; Siegmund W
    Int J Clin Pharmacol Ther; 1995 Dec; 33(12):653-7. PubMed ID: 8963482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the dose proportionality of the pharmacokinetics of sustained release sodium valproate.
    Wangemann M; Retzow A; Mazur D; Vens-Cappell B
    Int J Clin Pharmacol Ther; 2000 Aug; 38(8):395-401. PubMed ID: 10984013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absorption and presystemic metabolism of selegiline hydrochloride at different regions in the gastrointestinal tract in healthy males.
    Barrett JS; Szego P; Rohatagi S; Morales RJ; De Witt KE; Rajewski G; Ireland J
    Pharm Res; 1996 Oct; 13(10):1535-40. PubMed ID: 8899847
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.